REPLY: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI PRECISE-IVUS

Tsujita Kenichi; Sugiyama Seigo; Shimomura Hideki; Yamanaga Kenshi; Kaikita Koichi; Hokimoto Seiji; Ogawa Hisao

首页> 外文期刊>Journal of the American College of Cardiology >REPLY: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI PRECISE-IVUS

【24h】

REPLY: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI PRECISE-IVUS

机译：答复：依西替米贝和阿托伐他汀双重降脂策略对PCI PRECISE-IVUS后冠脉斑块消退的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the American College of Cardiology》 |2016年第2期|共4页
作者
Tsujita Kenichi; Sugiyama Seigo; Shimomura Hideki; Yamanaga Kenshi; Kaikita Koichi; Hokimoto Seiji; Ogawa Hisao;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. REPLY: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI PRECISE-IVUS [J] . Tsujita Kenichi, Sugiyama Seigo, Shimomura Hideki, Journal of the American College of Cardiology . 2016,第2期

机译：答复：依西替米贝和阿托伐他汀双重降脂策略对PCI PRECISE-IVUS后冠脉斑块消退的影响
2. Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI PRECISE-IVUS [J] . Giral Philippe, Hansel Boris, Chapman John Journal of the American College of Cardiology . 2016,第2期

机译：依泽替米贝和阿托伐他汀双重降脂策略对PCI PRECISE-IVUS后冠脉斑块消退的影响
3. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention - The Multicenter Randomized Controlled PRECISE-IVUS Trial [J] . Kenichi Tsujita, Seigo Sugiyama, Hitoshi Sumida, Journal of the American College of Cardiology . 2015,第5期

机译：双层脂质降低策略对ezetimibe和阿托伐他汀对经皮冠状动脉介入患者冠状动脉斑块回归的影响 - 多中心随机控制精确 - IVUS试验
4. PCSK9 polymorphism rs505151 affects lipid-lowering response to atorvastatin but does not influence ezetimibe therapy in Chilean subjects [C] . Zambrano T, Caama?o JM, Rosales A, International Congress on Coronary Artery Disease . 2011

机译：PCSK9多态性RS505151影响到阿托伐他汀的降脂响应，但不会影响智利受试者的ezetimibe治疗
5. Clarifying the Optimal Management Strategy for Patients with Possible Acute Coronary Syndrome with Intermediate Stenosis and High-Risk Plaque Morphology on Coronary Computed Tomographic Angiography [D] . Dwyer, Stephanie M. 2019

机译：明确可能的急性冠脉综合征合并中度狭窄和高风险斑块形态的冠状动脉计算机断层扫描血管造影的最佳管理策略
6. Effects of Statin Plus Ezetimibe on Coronary Plaques in Acute Coronary Syndrome Patients with Diabetes Mellitus: Sub-Analysis of PRECISE-IVUS Trial [O] . Koichiro Fujisue, Kenshi Yamanaga, Suguru Nagamatsu, 2021

机译：汀类药物加欧塞蒂米贝对急性冠状动脉综合征糖尿病患者冠状动脉斑块的影响：精确-Ivus试验的分析
7. Reply Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS [O] . Tsujita Kenichi, Sugiyama Seigo, Shimomura Hideki, 2016

机译：回答Ezetimibe和Atorvastatin的双重降脂策略对PCI后冠状动脉斑块消退的影响：PRECISE-IVUS

REPLY: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI PRECISE-IVUS

著录项

相似文献

相关主题

期刊订阅